FrancophonIA/ELRC3.0 huggingface dataset:
English: Orbactiv was at least as effective as vancomycin at treating the infection: 80.1% of patients treated with Orbactiv in the first study and 82.3% in the second study responded to treatment, compared with 82.9% and 78.9% respectively of patients treated with vancomycin.
Croatian: Lijek Orbactiv bio je barem jednako djelotvoran kao vankomicin u liječenju infekcije: 80,1 % bolesnika liječenih lijekom Orbactiv u prvom ispitivanju i 82,3 % u drugom ispitivanju odgovorilo je na terapiju, u usporedbi s 82,9 % i 78,9 % bolesnika liječenih vankomicinom.
English: The most common side effects with Orbactiv (which may affect 5 people or more in 100) are nausea (feeling sick), hypersensitivity (allergy) reactions or reactions at the site of infusion and headache.
Croatian: Najčešće nuspojave lijeka Orbactiv (mogu se javiti u više od 5 na 100 osoba) su mučnina (osjećaj slabosti), reakcije preosjetljivosti (alergične reakcije) ili reakcije na mjestu infuzije i glavobolja.
English: The CHMP considered that Orbactiv, which can be given as a single dose, could be a valuable alternative treatment option for acute bacterial infections of the skin and of skin structures.
Croatian: CHMP je zaključio da lijek Orbactiv, koji se može primijeniti u jednoj dozi, može biti vrijedna terapijska alternativa za akutne bakterijske infekcije kože i kožnih struktura.
English: What are the risks associated with Orbactiv?
Croatian: Koji su rizici povezani s lijekom Orbactiv?
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Orbactiv, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana, u sažetku opisa svojstava lijeka kao i u uputi o lijeku za lijek Orbactiv nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: Although Orbactiv's safety profile overall is similar to that of other glycopeptides, the CHMP noted that some side effects occurred more frequently such as abscesses and bone infections.
Croatian: Iako je sigurnosni profil lijeka Orbactiv načelno sličan profilu drugih glikopeptida, CHMP je zaključio da su pojedine nuspojave, poput apscesa i koštanih infekcija, češće nastupile.
English: It is not intended to provide practical advice on how to use Orbactiv.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Orbactiv.
English: The active substance in Orbactiv, oritavancin, is a type of antibiotic called a glycopeptide.
Croatian: Djelatna tvar lijeka Orbactiv, oritavancin, tip je antibiotika naziva glikopeptid.
English: Orbactiv is an antibiotic used in adults to treat acute (short-term) bacterial infections of the skin and of skin structures (tissue below the skin) such as cellulitis (inflammation of the deep skin tissue), skin abscesses and wound infections.
Croatian: Orbactiv je antibiotik koji se primjenjuje u odraslih osoba za liječenje akutnih (kratkotrajnih) bakterijskih infekcija kože i struktura kože (tkiva ispod kože) poput celulitisa (upale dubokog kožnog tkiva), kožnih apscesa i infekcija rana.
English: Orbactiv, given as a single infusion, was compared with a 7 to 10-day treatment with vancomycin (another glycopeptide) in two main studies involving a total of around 1,959 patients with acute bacterial infections of the skin and of skin structures, such as cellulitis, skin abscesses and wound infections.
Croatian: Orbactiv, primijenjen kao jedna infuzija, uspoređen je s terapijom vankomicinom (drugim glikopeptidom) u trajanju od sedam do deset dana u dva glavna ispitivanja koja su obuhvatila ukupno 1.959 bolesnika s akutnim bakterijskim infekcijama kože i kožnih struktura, poput celulitisa, kožnih apcesa i infekcija rana.
English: For more information about treatment with Orbactiv, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Orbactiv pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: A list of bacteria against which Orbactiv is active can be found in the summary of product characteristics (also part of the EPAR).
Croatian: Popis bakterija protiv kojih Orbactiv djeluje dostupan je u sažetku opisa svojstava lijeka (također dio EPAR-a).
English: Orbactiv is available as a powder to be made up into a solution for infusion (drip) into a vein and can only be obtained with a prescription.
Croatian: Orbactiv je dostupan kao prašak za pripravak otopine za infuziju (drip) u venu i izdaje se samo na liječnički recept.
English: What benefits of Orbactiv have been shown in studies?
Croatian: Koje su koristi lijeka Orbactiv utvrđene u ispitivanjima?
English: How does Orbactiv work?
Croatian: Kako djeluje Orbactiv?
English: How is Orbactiv used?
Croatian: Kako se Orbactiv koristi?
English: For practical information about using Orbactiv, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Orbactiv pročitajte u uputi o lijeku ili se obratite svom liječniku ili ljekarniku.
English: For the full list of all side effects and restrictions with Orbactiv, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja zabilježenih pri primjeni lijeka Orbactiv potražite u uputi o lijeku.
English: Very rare, not known*
Croatian: Vrlo rijetko, nepoznato
English: Date of latest renewal: 22 May 2014
Croatian: Datum posljednje obnove: 22. svibnja 2014
English: The optimal duration of treatment has not been formally established.
Croatian: Optimalno trajanje liječenja nije službeno utvrđeno.
English: The patients were followed for 30 days.
Croatian: Bolesnici su praćeni tijekom 30 dana.
English: Combined therapy should be started as early as possible after symptoms start and continued for at least four weeks.
Croatian: Kombiniranu terapiju treba započeti što prije nakon pojave simptoma te nastaviti tijekom najmanje četiri tjedna.
English: Macrogol 3000 (Polyethyleneglycol)
Croatian: Makrogol 3000 (polietilenglikol)
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate ili ste nedavno uzeli ili biste mogli uzeti bilo koje druge lijekove, uključujući i one koje ste nabavili bez recepta.
English: PHARMACEUTICAL FORM Film-coated tablet.
Croatian: OBLIK Filmom obložena tableta.
English: • if you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6);
Croatian: • ako ste alergični na klopidogrel ili neki drugi sastojak ovog lijeka (navedenu u dijelu 6.).
English: The mean CHADS2 score was 2.0 (range 0-6).
Croatian: Srednji CHADS2 bio je 2,0 (raspon od 0 do 6).
English: The patient population included 41.8 % women.
Croatian: Populacija bolesnika obuhvaćala je 41,8% žena.
English: Their frequency is defined using the following conventions: common (1/100 to <1/10); uncommon (1/1,000 to < 1/100); rare (1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Croatian: Njihova je učestalost definirana na sljedeći način: česte (≥ 1/100, < 1/10); manje česte (≥ 1/1000, < 1/100); rijetke (≥ 1/10 000, < 1/1000); vrlo rijetke (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
English: You should take Clopidogrel Mylan for as long as your doctor continues to prescribe it.
Croatian: Clopidogrel Mylan trebate uzimati sve dok Vam ga liječnik propisuje.
English: Medicinal products associated with bleeding risk: There is an increased risk of bleeding due to the potential additive effect.
Croatian: Lijekovi povezani s rizikom od krvarenja: povećan je rizik od krvarenja zbog mogućeg aditivnog učinka.
English: If you take more Clopidogrel Mylan than you should Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding.
Croatian: Ako uzmete više lijeka Clopidogrel Mylan nego što ste trebali: Odmah morate kontaktirati liječnika ili najbliži odjel hitne medicinske pomoći zbog povećanog rizika od krvarenja.
English: Detailed information is available on the European Medicines Agency website: http://www.ema.europa.eu/
Croatian: Detaljnije informacije dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu/
English: Thus, the results from this subset are in line with the overall trial results.
Croatian: Stoga su rezultati u toj podskupini bolesnika u skladu s ukupnih rezultatima ispitivanja.
English: Some other medicines may influence the use of Clopidogrel Mylan or vice versa.
Croatian: Neki lijekovi mogu utjecati na djelovanje Clopidogrela Mylan i obratno.
English: Atrial fibrillation
Croatian: Atrijska fibrilacija
English: The mean age was 71 years, 41.6% of patients were ≥75 years.
Croatian: Srednja je dob bila 71 godinu, 41,6% bolesnika bilo je ≥ 75 godina.
English: Warnings and precautions Talk to your doctor before taking Clopidogrel Mylan if any of the situations mentioned below apply to you:
Croatian: Upozorenja i mjere opreza: Obratite se svojem liječniku prije nego što uzmete Clopidogrel Mylan ako se na Vas odnosi bilo koje od dolje navedenih stanja:
English: Clopidogrel has been evaluated for safety in more than 44,000 patients, who have participated in clinical studies, including over 12,000 patients treated for 1 year or more.
Croatian: Sigurnost primjene klopidogrela ispitana je na više od 44.000 bolesnika koji su sudjelovali u kliničkim ispitivanjima, uključujući više od 12.000 bolesnika koji su lijek primali godinu ili više dana.
English: This leaflet was last revised in MM/YYYY.
Croatian: Ova uputa je zadnji puta revidirana u <mjesec/GGGG>
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/
Croatian: Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove http://www.ema.europa.eu/
English: The patient population included 19.7% women and 29.2% patients ≥ 65 years.
Croatian: Populacija bolesnika obuhvaćala je 19,7% žena i 29,2% bolesnika ≥ 65 godina.
English: 7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 30x1 film-coated tablets 50 film-coated tablets 50x1 film-coated tablets 56 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets
Croatian: 7 filmom obloženih tableta 14 filmom obloženih tableta 28 filmom obloženih tableta 30 filmom obloženih tableta 30x1 filmom obloženih tableta 50 filmom obloženih tableta 50x1 filmom obloženih tableta 56 filmom obloženih tableta 84 filmom obloženih tableta 90 filmom obloženih tableta 100 filmom obloženih tableta
English: 7 film-coated tablets - calendar blister: EU/1/09/559/012 14 film-coated tablets - calendar blister: EU/1/09/559/013 28 film-coated tablets - calendar blister: EU/1/09/559/014 56 film-coated tablets - calendar blister: EU/1/09/559/015 84 film-coated tablets - calendar blister: EU/1/09/559/016
Croatian: 7 filmom obloženih tableta - blister s kalendarom: EU/1/09/559/012 14 filmom obloženih tableta - blister s kalendarom: EU/1/09/559/013 28 filmom obloženih tableta - blister s kalendarom: EU/1/09/559/014 56 filmom obloženih tableta - blister s kalendarom: EU/1/09/559/015 84 filmom obloženih tableta - blister s kalendarom: EU/1/09/559/016
English: Mylan Hrvatska d.o.o.
Croatian: Hrvatska Mylan Hrvatska d.o.o.
English: Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Croatian: Od zdravstvenih djelatnika se traži da prijave svaku sumnju na nuspojavu lijeka putem: nacionalnog sustava prijave nuspojava navedenog u Dodatku V.
English: Moreover, the safety profile of clopidogrel in this subgroup of patients did not raise any particular concern.
Croatian: Sigurnosni profil klopidogrela u toj podskupini bolesnika nije dao konkretne razloge za zabrinutost.
English: In addition, a subgroup analysis by age suggested that the benefitof clopidogrel in patients over 75 years was less than that observed in patients ≤75 years.
Croatian: Dodatno, analiza podskupina prema dobi ukazuje da je korist od liječenja klopidogrelom manja u bolesnika iznad 75 godina nego u onih ≤ 75 godina.
English: Clopidogrel Mylan contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Croatian: Clopidogrel Mylan sadrži klopidogrel i pripada skupini lijekova koji se nazivaju antitrombocitni lijekovi.
English: For patients over 75 years of age clopidogrel should be initiated without a loading dose.
Croatian: Za bolesnike starije od 75 godina terapiju klopidogrelom valja započeti bez udarne doze.
English: Clinical trial data support use up to 12 months, and the maximum benefit was seen at 3 months (see section 5.1).
Croatian: Prema podacima dobivenima kliničkim ispitivanjima preporučuje se korištenje u trajanju do 12 mjeseci, a najveći je učinak primijećen nakon 3 mjeseca (vidjeti dio 5.1).
English: As a precautionary measure, breast-feeding should not be continued during treatment with Clopidogrel Mylan.
Croatian: Kao mjera opreza, treba prestati s dojenjem za vrijeme liječenja lijekom Clopidogrel Mylan.
English: In CURE, 823 (6.6%) patients received concomitant GPIIb/IIIa receptor antagonist therapy.
Croatian: Tijekom ispitivanja CURE, 823 (6,6%) bolesnika primala su istodobnu terapiju antagonistima GPIIb/IIIa receptorima.
English: The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A4.
Croatian: Aktivni metabolit nastaje većinom putem CYP2C19 uz sudjelovanje nekoliko drugih CYP enzima, uključujući CYP1A2, CYP2B6 i CYP3A4.
English: Your doctor should have prescribed Clopidogrel Mylan plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Croatian: Liječnik vam je Clopidogrel Mylan i acetilsalicilnu kiselinu smio propisati ako ne možete uzimati "oralne antikoagulanse" i u vas ne postoji rizik od jakog krvarenja.
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel Mylan and acetylsalicylic acid for this condition.
Croatian: Morali ste biti upozoreni da su "oralni antikoagulansi" učinkovitiji za tu bolest od acetilsalicilne kiseline ili kombinacije lijeka Clopidogrel Mylan i acetilsalicilne kiseline.
English: There have been a number of retrospective analyses, however, to evaluate this effect in patients treated with clopidogrel for whom there are genotyping results: CURE (n=2721), CHARISMA (n=2428), CLARITY-TIMI 28 (n=227), TRITON-TIMI 38 (n=1477), and ACTIVE-A (n=601), as well as a number of published cohort studies.
Croatian: Međutim, postoji veći broj retrospektivnih analiza za procjenu ovog učinka u bolesnika liječenih klopidogrelom za koje postoje rezultati genotipizacije: CURE (n = 2721), CHARISMA (n = 2428), CLARITY-TIMI 28 (n = 227), TRITON-TIMI 38 (n = 1477) te ACTIVE-A (n = 601), kao i određeni broj objavljenih kohortnih kliničkih studija.
English: Patients with a confirmed diagnosis of acquired haemophilia should be managed and treated by specialists, and clopidogrel should be discontinued
Croatian: Bolesnike s potvrđenom dijagnozom stečene hemofilije trebaju liječiti i tretirati specijalisti, a primjenu klopidogrela treba prekinuti.
English: If you forget to take a dose of Clopidogrel Mylan, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Croatian: Ako zaboravite uzeti jednu dozu lijeka Clopidogrel Mylan, ali se toga sjetite u roku od 12 sati, odmah uzmite tabletu, a sljedeću tabletu uzmite u uobičajeno vrijeme.
English: Sverige Mylan AB
Croatian: Mylan AB
English: Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC code: B01AC04.
Croatian: Farmakoterapijska skupina: Antitrombocitni agensi, inhibitori agregacije trombocita izuzev heparina, ATK oznaka: B01AC-04.
English: What Clopidogrel Mylan is and what it is used for
Croatian: Što je Clopidogrel Mylan i za što se koristi
English: Based on enrollment criteria, physicians enrolled patients in ACTIVE-W if they were candidates for vitamin K antagonist (VKA) therapy (such as warfarin).
Croatian: Liječnici su na temelju kriterija uključivanja prijavljivali bolesnike za ispitivanje ACTIVEW ako su bili kandidati za terapiju antagonistima vitamina K (kao što je varfarin).
English: The population included 27.8% women, 58.4% patients ≥ 60 years (26% ≥ 70 years) and 54.5% patients who received fibrinolytics.
Croatian: Populacija je obuhvaćala 27,8% žena, 58,4% bolesnika ≥ 60 godina (26% ≥ 70 godina) te 54,5% bolesnika koji su primali fibrinolitike.
English: If you become pregnant while taking Clopidogrel Mylan, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Croatian: Ako zatrudnite za vrijeme uzimanja lijeka Clopidogrel Mylan, odmah se posavjetujte s liječnikom, jer nije preporučeno uzimati klopidogrel za vrijeme trudnoće.
English: The ACTIVE-W and ACTIVE-A studies, separate trials in the ACTIVE program, included patients with atrial fibrillation (AF) who had at least one risk factor for vascular events.
Croatian: Ispitivanja ACTIVE-W i ACTIVE-A, dva zasebna ispitivanja u sklopu programa ACTIVE, obuhvaćala su bolesnike s atrijskom fibrilacijom s najmanje jednim faktorom rizika za vaskularne incidente.
English: Patients were treated for up to 5 years.
Croatian: Bolesnici su lijek primali u razdoblju do pet godina.
English: Other side effects include:
Croatian: Ostali sastojci su:
English: There was no observed effect on the rate of rehospitalisation for unstable angina.
Croatian: Nije primijećen učinak na stopu ponovne hospitalizacije zbog nestabilne angine.
English: Pink, round and biconvex film-coated tablets.
Croatian: Ružičaste, okrugle i bikonveksne filmom obložene tablete.
English: Since higher doses of ASA were associated with higher bleeding risk it is recommended that the dose of ASA should not be higher than 100 mg.
Croatian: Budući da su veće doze acetilsalicilne kiseline povezane s većim rizikom od krvarenja, ne preporučuju se doze acetilsalicilne kiseline veće od 100 mg.
English: The results obtained in populations with different characteristics (e.g. unstable angina or non-Q-wave MI, low to high risk levels, diabetes, need for revascularisation, age, gender, etc.) were consistent with the results of the primary analysis.
Croatian: Rezultati dobiveni u populacijama različitih karakteristika (npr. nestabilna angina ili infarkt miokarda bez Q-valova, niska ili visoka razina rizika, dijabetes, potreba za revaskularizacijom, dob, spol i dr.) sukladni su rezultatima primarne analize.
English: The clinically relevant adverse reactions observed in the CAPRIE, CURE, CLARITY, COMMIT and ACTIVE-A studies are discussed below.
Croatian: Klinički značajne nuspojave opažene u studijama CAPRIE, CURE, CLARITY,COMMIT i ACTIVE-A opisane su u daljnjem tekstu.
English: For the treatment of this condition your doctor may have placed a stent in the blocked or narrowed artery to restore effective blood flow.
Croatian: Liječnik vam je zbog toga možda ugradio stent u blokiranu ili suženu arteriju zbog ponovne uspostave djelotvornog protoka krvi.
English: CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy volunteers.
Croatian: Lijekovi koji su supstrati CYP2C8: pokazalo se da klopidogel povećava izloženost repaglinidu u zdravih dobrovoljaca.
English: For the 7, 14, 28, 56, 84 tablets (calendar blister) pack sizes, you can check the day on which you last took a tablet of Clopidogrel Mylan by referring to the calendar printed on the blister
Croatian: Kod pakiranja od 7, 14, 28, 56 i 84 tablete (blister s kalendarom) možete provjeriti dan kad ste zadnji put uzeli tabletu lijeka Chlopidogrel Mylan tako da provjerite kalendar otisnut na blisteru.
English: The efficacy of clopidogrel was observed independently of the dose of ASA (75-325 mg once daily).
Croatian: Djelotvornost klopidogrela zabilježena je neovisno o dozi ASA-a (75 - 325 mg jednom dnevno).
English: The co-primary endpoints were death from any cause and the first occurrence of re-infarction, stroke or death.
Croatian: Primarne krajnje točke bile su smrt zbog bilo kojeg uzroka te prva pojava ponovnog infarkta, moždanog udara ili smrti.
English: For minor cuts and injuries e.g., cutting yourself, shaving, this is usually of no concern.
Croatian: Za manje posjekotine i ozljede, primjerice nastale prilikom brijanja ili kad se sami porežete, to obično nije bitno.
English: • if you have kidney or liver disease.
Croatian: • Ako imate bolest bubrega ili jetre
English: Titanium dioxide (E171) Red iron oxide (E172) Yellow iron oxide (E172) Talc
Croatian: Ovojnica: polivinilni alkohol titanijev dioksid (E171) željezov oksid, crveni (E172) žuti željezov oksid (E172) talk
English: Clopidogrel significantly reduced the relative risk of death from any cause by 7% (p=0.029), and the relative risk of the combination of re-infarction, stroke or death by 9% (p=0.002), representing an absolute reduction of 0.5% and 0.9%, respectively.
Croatian: Klopidogrel je znatno smanjio relativni rizik od smrt zbog bilo kojeg uzroka za 7% (p = 0,029) te relativni rizik kombinacije ponovnog infarkta, moždanog udara ili smrti za 9% (p = 0,002), uz apsolutno smanjenje od 0,5% odnosno 0,9%.
English: Driving and using machines Clopidogrel Mylan is unlikely to affect your ability to drive or to use machines.
Croatian: Upravljanje vozilima i strojevima Clopidogrel Mylan ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima ili strojevima.
English: Because the active metabolite is formed by CYP450 enzymes, some of which are polymorphic or subject to inhibition by other medicinal products, not all patients will have adequate platelet inhibition.
Croatian: Budući da se aktivni metabolit klopidogrela stvara pomoću enzima CYP450, od kojih su neki polimorfni ili podložni inhibiciji od strane lijekova, svi bolesnici neće imati adekvatnu inhibiciju trombocita.
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel Mylan (4 tablets of 75 mg) once at the start of treatment.
Croatian: Ako ste imali jake bolove u prsištu (nestabilna angina ili srčani udar), liječnik Vam u početku liječenja može jednokratno dati 300 mg Clopidogrel Mylan (4 tablete od po 75 mg).
English: The safety and efficacy of clopidogrel have been evaluated in 5 double-blind studies involving over 88,000 patients: the CAPRIE study, a comparison of clopidogrel to ASA, and the CURE, CLARITY, COMMIT and ACTIVE-A studies comparing clopidogrel to placebo, both medicinal products given in combination with ASA and other standard therapy.
Croatian: Sigurnost i djelotvornost klopidogrela procijenjene su tijekom pet dvostruko slijepih ispitivanja u kojima je sudjelovalo više od 88.000 bolesnika: u ispitivanju CAPRIE, usporedbi klopidogrela s ASAom, te u ispitivanjima CURE, CLARITY, COMMIT i ACTIVE-A u kojima je klopidogrel uspoređivan s placebom, a oba su lijeka davana u kombinaciji s ASA-om i drugom standardnom terapijom.
English: The recommended dose for ASA was 75 to 100 mg/day.
Croatian: Preporučena je doza ASA-e bila 75 do 100 mg na dan.
English: If a dose is missed:
Croatian: Propuštena doza:
English: What you need to know before you take Clopidogrel Mylan
Croatian: Što morate znati prije nego počnete uzimati Clopidogrel Mylan
English: For more than 12 hours: patients should take the next dose at the regular scheduled time and should not double the dose.
Croatian: Ako je prošlo više od 12 sati: bolesnik treba sljedeću dozu uzeti prema uobičajenom rasporedu i ne smije uzeti dvostruku dozu.